Ensure Corona reports be available within 2 days: Delhi High Court

New Delhi: Delhi High Court asked the Delhi government to ensure that reports of Covid-19 tests conducted on suspected patients is available within 24-48 hours.

A bench of Justices Hima Kohli and Subramonium Prasad disposed a PIL filed by Advocate Rakesh Malhotra seeking directions to the Centre and the state government to ensure speedy testing of Covid-19 patients without any delay in providing the results.

Rakesh Malhotra said that, “Media reports showed that over the past month, the number of swab samples pending for tests in Delhi, which started with 470 on April1, had gone up by 7 times and reached 3,295, on April 29.”

On its part, the government informed the bench that to get faster results, it was sending samples to 23 labs — 13 private and 10 public sector — in the capital and not to Noida.

The state government placed an order issued by the Health and Family Department before the bench that said, “the notification in this regard had been extended by two weeks so that samples be sent within the capital instead of National Institute of Biologicals in Noida, where the testing process was slow leading to increase in pendency.”

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India